Drug Type Small molecule drug |
Synonyms Xerclear |
Mechanism DNA-directed DNA polymerase inhibitors, GR agonists(Glucocorticoid receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (31 Jul 2009), |
Regulation- |
Molecular FormulaC29H41N5O8 |
InChIKeyMDCGTBRYRLWFJI-WDCKKOMHSA-N |
CAS Registry439279-66-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Herpes Labialis | US | 31 Jul 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Herpes Labialis | Phase 1 | KR | - |
Phase 3 | 2,437 | nkmxpcszxl(tbgyfwystj) = aowshjmmcr zzasejdykh (kvzozxgmxs ) | Positive | 01 Apr 2011 |